Lido Advisors LLC Reduces Position in CME Group (CME)

Lido Advisors LLC trimmed its position in CME Group (NASDAQ:CME) by 26.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,149 shares of the financial services provider’s stock after selling 1,154 shares during the quarter. Lido Advisors LLC’s holdings in CME Group were worth $459,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in CME. ARK Investment Management LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $120,000. Valeo Financial Advisors LLC acquired a new stake in shares of CME Group during the third quarter worth approximately $124,000. AlphaOne Investment Services LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $146,000. Mosaic Family Wealth LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $146,000. Finally, Truewealth LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $157,000. Institutional investors own 83.11% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other news, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total value of $31,982.00. Following the transaction, the director now owns 3,809 shares of the company’s stock, valued at $609,097.19. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 3,299 shares of CME Group stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. In the last three months, insiders sold 40,699 shares of company stock worth $6,266,062. Insiders own 0.57% of the company’s stock.

Several research firms recently commented on CME. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. Zacks Investment Research cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. Bank of America raised their price target on shares of CME Group from $175.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, March 8th. BidaskClub cut shares of CME Group from a “strong-buy” rating to a “buy” rating in a report on Thursday, March 15th. Finally, Barclays raised their price target on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $163.69.

CME traded down $4.73 during midday trading on Friday, hitting $158.26. 1,313,788 shares of the company’s stock traded hands, compared to its average volume of 2,112,036. The firm has a market cap of $55,479.36, a PE ratio of 33.18, a PEG ratio of 2.25 and a beta of 0.56. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.03 and a current ratio of 1.03. CME Group has a one year low of $114.82 and a one year high of $171.71.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The company had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. During the same quarter last year, the firm posted $1.14 earnings per share. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. sell-side analysts anticipate that CME Group will post 6.89 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were given a $0.70 dividend. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.77%. CME Group’s dividend payout ratio (DPR) is currently 58.70%.

COPYRIGHT VIOLATION NOTICE: “Lido Advisors LLC Reduces Position in CME Group (CME)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/07/lido-advisors-llc-reduces-stake-in-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply